Despite IL-6’s superior sensitivity compared to CRP (74% vs. 29%), its elevation in 57% of FUO episodes and failure to detect 26% of bacteremia precluded standalone use for antibiotic decisions, underscoring the limitations of single biomarkers in neutropenic fever management. The gene discussed is CRP; the disease is bacterial infectious disease with sepsis.